Antisense-designed peptides: a comparative study focusing on possible complements to angiotensin II.

Autor: Holsworth DD; Parke-Davis Pharmaceutical Research, Division of Warner-Lambert, Ann Arbor, MI., Kiely JS, Root-Bernstein RS, Overhiser RW
Jazyk: angličtina
Zdroj: Peptide research [Pept Res] 1994 Jul-Aug; Vol. 7 (4), pp. 185-93.
Abstrakt: A comprehensive study of antisense peptides possibly complementary to angiotensin II (AII) is described. Antisense peptides of AII were designed using two different procedures outlined by Blalock and Root-Bernstein. Also, peptide complements designed to interact as homologs of AII were investigated. Three methods were used to detect binding between these peptides and AII. Several antisense-designed peptides were studied with unprotected termini to compare the effects of protected vs. unprotected termini. It was determined that the protected antisense-designed peptides derived from Root-Bernstein's methods interacted (high micro-molar range) directly with AII, while those protected antisense peptides derived from Blalock's method interacted only with the AII receptor. Two novel AII antagonists were discovered using this technology, a Root-Bernstein derived unprotected complementary peptide (H2N-K-G-V-Y-M-H-A-L-CO2H) and a Blalock derived unprotected antisense peptide (H2N-E-G-V-Y-V-H-P-V-CO2H), which exhibited 5 microM and 70 nM affinity toward the AII receptor, respectively.
Databáze: MEDLINE